Margaret R Jorgenson

53PUBLICATIONS
34CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Major global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (53)

|Jul 22, 2026
Real World Utilization of Protocolized T-Cell Immunity Panel Screening in Cytomegalovirus Seropositive Kidney Transplant Recipients.

|Dec 18, 2025
De Novo Letermovir After Cytomegalovirus Seropositive Kidney Transplant Improves Toxicity and Mycophenolate Tolerance Over the Current Standard of Care.

Hanna L Kleiboeker, Margaret R Jorgenson, Michael J Scolarici

|Apr 28, 2025
De Novo Letermovir for Cytomegalovirus Prophylaxis in High-Risk Liver Transplant Recipients.

Hanna L Kleiboeker, Jillian L Descourouez, Chris M Saddler

|Jan 16, 2025
The UW Experience: Feasibility of De Novo Letermovir for Primary Prophylaxis After Abdominal Solid Organ Transplant.

Jillian L Descourouez, Hanna Kleiboeker, Christopher M Saddler

|Dec 11, 2023
Incidence and outcomes of fever of unknown origin after kidney transplant in the modern era.

Margaret R Jorgenson, Sandesh Parajuli, Hanna L Kleiboeker

|Nov 17, 2023
Risk factors and outcomes of persistent post-transplant hypotension among simultaneous pancreas and kidney transplant recipients.

Fahad Aziz, Didier Mandelbrot, Margaret Jorgenson

Pageof 9

Frequent Collaborators

20 joint publications

Sandesh Parajuli

18 joint publications

Jillian L Descourouez

15 joint publications

Didier Mandlebrot

9 joint publications

Fahad Aziz